ANHUIEXPRESSWAY(00995) plans to invest approximately 3.0187 billion yuan to acquire 7% equity of Shandong Hi-speed(600350.SH)
Anhui WanTong Expressway Co., Ltd. (00995) announced that on October 21, 2025, the company entered into a share transfer agreement...
ANHUIEXPRESSWAY (00995) announced that on October 21, 2025, the company entered into a share transfer agreement to acquire approximately 338.4 million shares of A-shares of Shandong Hi-speed Corporation Limited (600350.SH) from Shandong Hi-speed Group Limited, representing 7% of the total issued share capital of Shandong Hi-speed Corporation Limited as of the date of this announcement. The total consideration of the acquisition is approximately RMB 3.0187 billion 44, equivalent to RMB 8.92 per share of the transferred shares.
It is reported that the target company is mainly engaged in investment and operation of transportation infrastructure, as well as equity investment in the upstream and downstream related fields of the highway industry chain. The revenue sources of the target company cover multiple core business segments, including toll operation of expressways, intelligent transportation, commodity sales, railway transportation, expressway management services, and engineering construction.
The announcement stated that the target company is an excellent company in the industry, and the acquisition of a portion of the target company's shares will further expand the company's effective investment, effectively promote the company's core business to become stronger, better, and bigger. After the completion of this acquisition, the company can further deepen its strategic cooperation relationship with the target company, which will help both parties continue deep business cooperation and exchanges.
Based on this, the company may consider further acquiring shares of the target company in the future, and will comply with relevant regulations of the listing rules in a timely manner.
Related Articles

US Stock Market Move | Amazon.com, Inc. (AMZN.US) is up more than 2%, with the company accelerating its automation process.

US Stock Market Move | Halliburton (HAL.US) rose more than 9% with Q3 results exceeding expectations.
.png)
Sichuan Biokin Pharmaceutical (688506.SH): Clinical trial of injectable BL-M24D1 (ADC) drug approved.
US Stock Market Move | Amazon.com, Inc. (AMZN.US) is up more than 2%, with the company accelerating its automation process.

US Stock Market Move | Halliburton (HAL.US) rose more than 9% with Q3 results exceeding expectations.

Sichuan Biokin Pharmaceutical (688506.SH): Clinical trial of injectable BL-M24D1 (ADC) drug approved.
.png)
RECOMMEND

Why European Automakers Are Opposing Dutch Sanctions
20/10/2025

Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025

Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025